Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].

Medicina clinica - 4 Sept 2004

Hernández-Charro Blanca, Moreno Sira, Valiente Alberto, Manubens José María, Villar María Dolores, Ramos-Arroyo María Antonia

Abstract excerpt

BACKGROUND AND OBJECTIVE: The association between the presence of the allele APOE*epsilon4 (apolipoprotein E) and sporadic Alzheimer disease (AD) has been long established. However, the possible influence of other genetic factors is still under debate. This study investigated the role of the a 1-antichymotrypsin (ACT) gene as a susceptibility factor for developing late-onset AD in the population of Navarra....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Logistic Models
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to alpha 1-Antichymotrypsin

Share to Alzheimer Disease

Share to Apolipoproteins E

Share to Case-Control Studies

Share to Gene Frequency

Share to Odds Ratio

Source

Identifiers

PMID: 15482730
DOI: 10.1016/s0025-7753(04)74479-6

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].PMID 15482730Read ↗

Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease.Semantic proximity Read ↗

No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease.Semantic proximity Read ↗

Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population.Semantic proximity Read ↗

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.Semantic proximity Read ↗

Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.Semantic proximity Read ↗

Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.Semantic proximity Read ↗

alpha-1-Antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease.Semantic proximity Read ↗

A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.Semantic proximity Read ↗

[Apolipoprotein E 4 gene is a risk factor for Alzheimer's disease].Semantic proximity Read ↗

Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.Semantic proximity Read ↗

Apolipoprotein E: risk factor for Alzheimer disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.